Inventor
GODTFREDSEN SVEN ERIK
US8 patents
⚠️ This page may combine multiple inventors who share the name “GODTFREDSEN SVEN ERIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FENG LILI
2 patentsUS8877938B2Nov 4, 2014
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
FENG LILI44 citations95
US9388134B2Jul 12, 2016
Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations
FENG LILI5 citations81
NOVARTIS PHARMACEUTICALS CORP
2 patentsUS11642329B2May 9, 2023
Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
NOVARTIS PHARMACEUTICALS CORP0 citations60
US11096918B2Aug 24, 2021
Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations
NOVARTIS PHARMACEUTICALS CORP0 citations60